{
    "info": {
        "nct_id": "NCT03206177",
        "official_title": "Feasibility IB Trial of Paclitaxel/Carboplatin + Galunisertib (a Small Molecule Inhibitor of the Kinase Domain of Type 1 TGF-B Receptor) in Patients With Newly Diagnosed, Persistent or Recurrent Carcinosarcoma of the Uterus or Ovary",
        "inclusion_criteria": "1. Women â‰¥ 18 years old with a diagnosis of primary, recurrent or progressive uterine, ovarian, fallopian tube or peritoneal carcinosarcoma, for whom treatment with combination paclitaxel and carboplatin is recommended.\n2. Written informed consent/assent prior to any study-specific procedures\n3. Eastern Cooperative Oncology Group (ECOG) performance status 0-2\n4. Tissue available for translational study (paraffin block or new biopsy) .\n5. Adequate bone marrow, renal, and hepatic function as defined per protocol.\n6. No disease-modifying therapy, including investigational treatments, within 28 days prior to initiation of study treatment.\n7. Ability to swallow tablets\n8. For Women of child-bearing potential:Willingness to use a highly effective method of contraception during the study and for 6 months following the last dose of galunisertib. Negative beta human chorionic gonadotropin pregnancy test documented within 7 days prior to initiation of study drug.\n9. Patient must have measurable disease before the treatment\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 99 Years",
        "exclusion_criteria": "1. Planned radiotherapy during or after the study chemotherapy prior to disease progression.\n2. Receipt of chemotherapy or radiation within 28 days of study treatment\n3. Have had a major surgical procedure or a significant traumatic injury within 28 days prior to study treatment; Minor procedures such as biopsy within 7 days prior to study treatment are allowed.\n4. Active infection that would preclude receipt of chemotherapy\n5. Moderate or severe cardiovascular disease per protocol\n6. Active pregnancy or lactation\n7. Second primary malignancy for which treatment during the study period would be recommended if this cancer were not also present.\n8. Prior malignancy requiring treatment within the last 3 years\n9. Use of another investigational product or device within 4 weeks of study entry or during study participation.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "9. Patient must have measurable disease before the treatment",
                "criterions": [
                    {
                        "exact_snippets": "Patient must have measurable disease before the treatment",
                        "criterion": "disease",
                        "requirement": {
                            "requirement_type": "measurability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Patient must have measurable disease before the treatment",
                        "criterion": "disease",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "before the treatment"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Patient must have measurable disease before the treatment",
                        "criterion": "disease",
                        "requirement": {
                            "requirement_type": "measurability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Patient must have measurable disease before the treatment",
                        "criterion": "disease",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "before the treatment"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have minimum age of 18 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "7. Ability to swallow tablets",
                "criterions": [
                    {
                        "exact_snippets": "Ability to swallow tablets",
                        "criterion": "ability to swallow tablets",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Ability to swallow tablets",
                        "criterion": "ability to swallow tablets",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must be FEMALE",
                "criterions": [
                    {
                        "exact_snippets": "Must be FEMALE",
                        "criterion": "sex",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Must be FEMALE",
                        "criterion": "sex",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "5. Adequate bone marrow, renal, and hepatic function as defined per protocol.",
                "criterions": [
                    {
                        "exact_snippets": "Adequate bone marrow ... function",
                        "criterion": "bone marrow function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate ... renal ... function",
                        "criterion": "renal function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate ... hepatic function",
                        "criterion": "hepatic function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Adequate bone marrow ... function",
                        "criterion": "bone marrow function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate ... renal ... function",
                        "criterion": "renal function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate ... hepatic function",
                        "criterion": "hepatic function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Eastern Cooperative Oncology Group (ECOG) performance status 0-2",
                "criterions": [
                    {
                        "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status 0-2",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status 0-2",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "6. No disease-modifying therapy, including investigational treatments, within 28 days prior to initiation of study treatment.",
                "criterions": [
                    {
                        "exact_snippets": "No disease-modifying therapy, including investigational treatments, within 28 days prior to initiation of study treatment.",
                        "criterion": "disease-modifying therapy",
                        "requirement": {
                            "requirement_type": "absence_within_timeframe",
                            "expected_value": {
                                "operator": "<",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "No ... investigational treatments, within 28 days prior to initiation of study treatment.",
                        "criterion": "investigational treatments",
                        "requirement": {
                            "requirement_type": "absence_within_timeframe",
                            "expected_value": {
                                "operator": "<",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "No disease-modifying therapy, including investigational treatments, within 28 days prior to initiation of study treatment.",
                        "criterion": "disease-modifying therapy",
                        "requirement": {
                            "requirement_type": "absence_within_timeframe",
                            "expected_value": {
                                "operator": "<",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "No ... investigational treatments, within 28 days prior to initiation of study treatment.",
                        "criterion": "investigational treatments",
                        "requirement": {
                            "requirement_type": "absence_within_timeframe",
                            "expected_value": {
                                "operator": "<",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "8. For Women of child-bearing potential:Willingness to use a highly effective method of contraception during the study and for 6 months following the last dose of galunisertib. Negative beta human chorionic gonadotropin pregnancy test documented within 7 days prior to initiation of study drug.",
                "criterions": [
                    {
                        "exact_snippets": "Women of child-bearing potential",
                        "criterion": "sex and reproductive potential",
                        "requirement": {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        }
                    },
                    {
                        "exact_snippets": "Women of child-bearing potential",
                        "criterion": "sex and reproductive potential",
                        "requirement": {
                            "requirement_type": "reproductive_potential",
                            "expected_value": "of child-bearing potential"
                        }
                    },
                    {
                        "exact_snippets": "Willingness to use a highly effective method of contraception during the study and for 6 months following the last dose of galunisertib",
                        "criterion": "contraception use",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Willingness to use a highly effective method of contraception during the study and for 6 months following the last dose of galunisertib",
                        "criterion": "contraception use",
                        "requirement": {
                            "requirement_type": "method",
                            "expected_value": "highly effective"
                        }
                    },
                    {
                        "exact_snippets": "Willingness to use a highly effective method of contraception during the study and for 6 months following the last dose of galunisertib",
                        "criterion": "contraception use",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": "during the study and for 6 months following the last dose of galunisertib"
                        }
                    },
                    {
                        "exact_snippets": "Negative beta human chorionic gonadotropin pregnancy test documented within 7 days prior to initiation of study drug",
                        "criterion": "pregnancy test",
                        "requirement": {
                            "requirement_type": "test_type",
                            "expected_value": "beta human chorionic gonadotropin"
                        }
                    },
                    {
                        "exact_snippets": "Negative beta human chorionic gonadotropin pregnancy test documented within 7 days prior to initiation of study drug",
                        "criterion": "pregnancy test",
                        "requirement": {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    },
                    {
                        "exact_snippets": "Negative beta human chorionic gonadotropin pregnancy test documented within 7 days prior to initiation of study drug",
                        "criterion": "pregnancy test",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "within 7 days prior to initiation of study drug"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Women of child-bearing potential",
                                "criterion": "sex and reproductive potential",
                                "requirement": {
                                    "requirement_type": "sex",
                                    "expected_value": "female"
                                }
                            },
                            {
                                "exact_snippets": "Women of child-bearing potential",
                                "criterion": "sex and reproductive potential",
                                "requirement": {
                                    "requirement_type": "reproductive_potential",
                                    "expected_value": "of child-bearing potential"
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Willingness to use a highly effective method of contraception during the study and for 6 months following the last dose of galunisertib",
                                "criterion": "contraception use",
                                "requirement": {
                                    "requirement_type": "willingness",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Willingness to use a highly effective method of contraception during the study and for 6 months following the last dose of galunisertib",
                                "criterion": "contraception use",
                                "requirement": {
                                    "requirement_type": "method",
                                    "expected_value": "highly effective"
                                }
                            },
                            {
                                "exact_snippets": "Willingness to use a highly effective method of contraception during the study and for 6 months following the last dose of galunisertib",
                                "criterion": "contraception use",
                                "requirement": {
                                    "requirement_type": "duration",
                                    "expected_value": "during the study and for 6 months following the last dose of galunisertib"
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Negative beta human chorionic gonadotropin pregnancy test documented within 7 days prior to initiation of study drug",
                                "criterion": "pregnancy test",
                                "requirement": {
                                    "requirement_type": "test_type",
                                    "expected_value": "beta human chorionic gonadotropin"
                                }
                            },
                            {
                                "exact_snippets": "Negative beta human chorionic gonadotropin pregnancy test documented within 7 days prior to initiation of study drug",
                                "criterion": "pregnancy test",
                                "requirement": {
                                    "requirement_type": "result",
                                    "expected_value": "negative"
                                }
                            },
                            {
                                "exact_snippets": "Negative beta human chorionic gonadotropin pregnancy test documented within 7 days prior to initiation of study drug",
                                "criterion": "pregnancy test",
                                "requirement": {
                                    "requirement_type": "timing",
                                    "expected_value": "within 7 days prior to initiation of study drug"
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Written informed consent/assent prior to any study-specific procedures",
                "criterions": [
                    {
                        "exact_snippets": "Written informed consent/assent prior to any study-specific procedures",
                        "criterion": "informed consent/assent",
                        "requirement": {
                            "requirement_type": "documentation",
                            "expected_value": "written"
                        }
                    },
                    {
                        "exact_snippets": "Written informed consent/assent prior to any study-specific procedures",
                        "criterion": "informed consent/assent",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "prior to any study-specific procedures"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Written informed consent/assent prior to any study-specific procedures",
                        "criterion": "informed consent/assent",
                        "requirement": {
                            "requirement_type": "documentation",
                            "expected_value": "written"
                        }
                    },
                    {
                        "exact_snippets": "Written informed consent/assent prior to any study-specific procedures",
                        "criterion": "informed consent/assent",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "prior to any study-specific procedures"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have maximum age of 99 Years",
                "criterions": [
                    {
                        "exact_snippets": "maximum age of 99 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 99,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "maximum age of 99 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 99,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "8. Prior malignancy requiring treatment within the last 3 years",
                "criterions": [
                    {
                        "exact_snippets": "Prior malignancy requiring treatment within the last 3 years",
                        "criterion": "prior malignancy",
                        "requirement": {
                            "requirement_type": "treatment requirement",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Prior malignancy requiring treatment within the last 3 years",
                        "criterion": "prior malignancy",
                        "requirement": {
                            "requirement_type": "time since treatment",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Prior malignancy requiring treatment within the last 3 years",
                        "criterion": "prior malignancy",
                        "requirement": {
                            "requirement_type": "treatment requirement",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Prior malignancy requiring treatment within the last 3 years",
                        "criterion": "prior malignancy",
                        "requirement": {
                            "requirement_type": "time since treatment",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Receipt of chemotherapy or radiation within 28 days of study treatment",
                "criterions": [
                    {
                        "exact_snippets": "Receipt of chemotherapy ... within 28 days of study treatment",
                        "criterion": "chemotherapy",
                        "requirement": {
                            "requirement_type": "receipt_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Receipt of ... radiation within 28 days of study treatment",
                        "criterion": "radiation",
                        "requirement": {
                            "requirement_type": "receipt_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Receipt of chemotherapy ... within 28 days of study treatment",
                        "criterion": "chemotherapy",
                        "requirement": {
                            "requirement_type": "receipt_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Receipt of ... radiation within 28 days of study treatment",
                        "criterion": "radiation",
                        "requirement": {
                            "requirement_type": "receipt_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Have had a major surgical procedure or a significant traumatic injury within 28 days prior to study treatment; Minor procedures such as biopsy within 7 days prior to study treatment are allowed.",
                "criterions": [
                    {
                        "exact_snippets": "Have had a major surgical procedure ... within 28 days prior to study treatment",
                        "criterion": "major surgical procedure",
                        "requirement": {
                            "requirement_type": "time since procedure",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "significant traumatic injury within 28 days prior to study treatment",
                        "criterion": "significant traumatic injury",
                        "requirement": {
                            "requirement_type": "time since injury",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Minor procedures such as biopsy within 7 days prior to study treatment are allowed",
                        "criterion": "minor procedures (such as biopsy)",
                        "requirement": {
                            "requirement_type": "time since procedure",
                            "expected_value": {
                                "operator": ">=",
                                "value": 0,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Minor procedures such as biopsy within 7 days prior to study treatment are allowed",
                        "criterion": "minor procedures (such as biopsy)",
                        "requirement": {
                            "requirement_type": "time since procedure",
                            "expected_value": {
                                "operator": "<=",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "not_criteria": {
                            "not_criteria": {
                                "exact_snippets": "Have had a major surgical procedure ... within 28 days prior to study treatment",
                                "criterion": "major surgical procedure",
                                "requirement": {
                                    "requirement_type": "time since procedure",
                                    "expected_value": {
                                        "operator": ">=",
                                        "value": 28,
                                        "unit": "days"
                                    }
                                }
                            }
                        }
                    },
                    {
                        "not_criteria": {
                            "not_criteria": {
                                "exact_snippets": "significant traumatic injury within 28 days prior to study treatment",
                                "criterion": "significant traumatic injury",
                                "requirement": {
                                    "requirement_type": "time since injury",
                                    "expected_value": {
                                        "operator": ">=",
                                        "value": 28,
                                        "unit": "days"
                                    }
                                }
                            }
                        }
                    },
                    {
                        "and_criteria": [
                            {
                                "not_criteria": {
                                    "not_criteria": {
                                        "exact_snippets": "Minor procedures such as biopsy within 7 days prior to study treatment are allowed",
                                        "criterion": "minor procedures (such as biopsy)",
                                        "requirement": {
                                            "requirement_type": "time since procedure",
                                            "expected_value": {
                                                "operator": ">=",
                                                "value": 0,
                                                "unit": "days"
                                            }
                                        }
                                    }
                                }
                            },
                            {
                                "not_criteria": {
                                    "not_criteria": {
                                        "exact_snippets": "Minor procedures such as biopsy within 7 days prior to study treatment are allowed",
                                        "criterion": "minor procedures (such as biopsy)",
                                        "requirement": {
                                            "requirement_type": "time since procedure",
                                            "expected_value": {
                                                "operator": "<=",
                                                "value": 7,
                                                "unit": "days"
                                            }
                                        }
                                    }
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "4. Active infection that would preclude receipt of chemotherapy",
                "criterions": [
                    {
                        "exact_snippets": "Active infection that would preclude receipt of chemotherapy",
                        "criterion": "active infection",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": "sufficient to preclude receipt of chemotherapy"
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Active infection that would preclude receipt of chemotherapy",
                    "criterion": "active infection",
                    "requirement": {
                        "requirement_type": "severity",
                        "expected_value": "sufficient to preclude receipt of chemotherapy"
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "7. Second primary malignancy for which treatment during the study period would be recommended if this cancer were not also present.",
                "criterions": [
                    {
                        "exact_snippets": "Second primary malignancy",
                        "criterion": "second primary malignancy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "for which treatment during the study period would be recommended if this cancer were not also present",
                        "criterion": "need for treatment of second primary malignancy during the study period",
                        "requirement": {
                            "requirement_type": "treatment recommendation during study period if index cancer not present",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Second primary malignancy",
                        "criterion": "second primary malignancy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "for which treatment during the study period would be recommended if this cancer were not also present",
                        "criterion": "need for treatment of second primary malignancy during the study period",
                        "requirement": {
                            "requirement_type": "treatment recommendation during study period if index cancer not present",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "6. Active pregnancy or lactation",
                "criterions": [
                    {
                        "exact_snippets": "Active pregnancy",
                        "criterion": "pregnancy",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": "active"
                        }
                    },
                    {
                        "exact_snippets": "lactation",
                        "criterion": "lactation",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": "active"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Active pregnancy",
                        "criterion": "pregnancy",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": "active"
                        }
                    },
                    {
                        "exact_snippets": "lactation",
                        "criterion": "lactation",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": "active"
                        }
                    }
                ]
            }
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "identified_line": {
                "line": "4. Tissue available for translational study (paraffin block or new biopsy) .",
                "criterions": [
                    {
                        "exact_snippets": "Tissue available for translational study (paraffin block or new biopsy)",
                        "criterion": "tissue for translational study",
                        "requirement": {
                            "requirement_type": "availability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Tissue available for translational study (paraffin block or new biopsy)",
                        "criterion": "tissue for translational study",
                        "requirement": {
                            "requirement_type": "type",
                            "expected_value": [
                                "paraffin block",
                                "new biopsy"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "1. Women â‰¥ 18 years old with a diagnosis of primary, recurrent or progressive uterine, ovarian, fallopian tube or peritoneal carcinosarcoma, for whom treatment with combination paclitaxel and carboplatin is recommended.",
                "criterions": [
                    {
                        "exact_snippets": "Women",
                        "criterion": "sex",
                        "requirement": {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        }
                    },
                    {
                        "exact_snippets": "â‰¥ 18 years old",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    },
                    {
                        "exact_snippets": "diagnosis of primary, recurrent or progressive uterine, ovarian, fallopian tube or peritoneal carcinosarcoma",
                        "criterion": "carcinosarcoma diagnosis",
                        "requirement": {
                            "requirement_type": "diagnosis_status",
                            "expected_value": [
                                "primary",
                                "recurrent",
                                "progressive"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "diagnosis of primary, recurrent or progressive uterine, ovarian, fallopian tube or peritoneal carcinosarcoma",
                        "criterion": "carcinosarcoma diagnosis",
                        "requirement": {
                            "requirement_type": "anatomic_site",
                            "expected_value": [
                                "uterine",
                                "ovarian",
                                "fallopian tube",
                                "peritoneal"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "for whom treatment with combination paclitaxel and carboplatin is recommended",
                        "criterion": "treatment recommendation",
                        "requirement": {
                            "requirement_type": "treatment_recommendation",
                            "expected_value": "combination paclitaxel and carboplatin"
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_exclusion": [
        {
            "identified_line": {
                "line": "9. Use of another investigational product or device within 4 weeks of study entry or during study participation.",
                "criterions": [
                    {
                        "exact_snippets": "Use of another investigational product or device within 4 weeks of study entry",
                        "criterion": "use of another investigational product or device",
                        "requirement": {
                            "requirement_type": "time since last use",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Use of another investigational product or device ... during study participation",
                        "criterion": "use of another investigational product or device",
                        "requirement": {
                            "requirement_type": "use during study participation",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Use of another investigational product or device within 4 weeks of study entry",
                        "criterion": "use of another investigational product or device",
                        "requirement": {
                            "requirement_type": "time since last use",
                            "expected_value": {
                                "operator": "<",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Use of another investigational product or device ... during study participation",
                        "criterion": "use of another investigational product or device",
                        "requirement": {
                            "requirement_type": "use during study participation",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1. Planned radiotherapy during or after the study chemotherapy prior to disease progression.",
                "criterions": [
                    {
                        "exact_snippets": "Planned radiotherapy during or after the study chemotherapy prior to disease progression.",
                        "criterion": "planned radiotherapy",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": [
                                "during the study chemotherapy",
                                "after the study chemotherapy"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Planned radiotherapy during or after the study chemotherapy prior to disease progression.",
                        "criterion": "planned radiotherapy",
                        "requirement": {
                            "requirement_type": "before disease progression",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "5. Moderate or severe cardiovascular disease per protocol",
                "criterions": [
                    {
                        "exact_snippets": "Moderate or severe cardiovascular disease",
                        "criterion": "cardiovascular disease",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": [
                                "moderate",
                                "severe"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_miscellaneous": []
}